Search for: "Mylan Pharms, Inc."
Results 81 - 96
of 96
Sorted by Relevance
|
Sort by Date
4 May 2011, 7:52 am
Brand Name Opioid Products Generic Name Trade Name Applicant/Sponsors Fentanyl Duragesic Extended Release Transdermal System Ortho McNeil Janssen Hydromorphone *Palladone Extended Release Capsules Purdue Pharma Methadone Dolophine Tablets Roxanne Morphine Avinza® Extended Release Capsules King Pharms Morphine Kadian® Extended Release Capsules Actavis Morphine MS Contin Extended Release Tablets Purdue Pharma… [read post]
19 Feb 2016, 11:57 am
Isonas, Inc., 2014 WL 10988340 (C.D. [read post]
26 Sep 2022, 4:49 am
Mylan. [read post]
10 Sep 2018, 10:17 am
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
28 Dec 2010, 10:58 am
USA, Inc. v. [read post]
31 Mar 2010, 1:58 pm
Teva Pharm., USA, Inc., 429 F.3d 1364, 1377 (Fed. [read post]
6 Aug 2009, 11:24 pm
Mylan Labs., Inc., 520 F.3d 1358, 1364 (Fed. [read post]
6 Aug 2011, 2:27 pm
.'s policy with Warren Funeral Chapel Inc. covered emotional distress under its definition of bodily injury. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US:… [read post]
13 Mar 2024, 7:24 pm
” (see also Hoechst-Roussel Pharms., Inc. v. [read post]
7 May 2010, 11:11 am
See Genentech, Inc. v. [read post]
27 Mar 2012, 1:09 am
See Mylan Labs., Inc. v. [read post]
9 Feb 2024, 11:08 am
” Similarly, as show in the Mylan Laby’s, Inc. v. [read post]
13 Oct 2014, 9:01 am
Since then, no generic company has gained approval by the Food and Drug Administration to market a generic version of the drug, although the FDA in August agreed to review a new application from one of the generic firms — Momenta Pharmaceuticals, Inc. [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
